Atrial fibrillation (AF) — stroke prevention
- Estimate thromboembolic + bleeding risk
- DOAC preferred over warfarin for most AF
- Apixaban often favored if bleeding concern
- Warfarin for mechanical valve/mitral stenosis
- Renal function affects DOAC choice/dose
- Antiplatelet ≠ substitute for anticoagulation
Use at a glance
- Estimate thromboembolic + bleeding risk
Practical pearls
- DOAC preferred over warfarin for most AF
Treatment options
- Warfarin for mechanical valve/mitral stenosis
- Antiplatelet ≠ substitute for anticoagulation
Choosing treatment
- Apixaban often favored if bleeding concern
- Renal function affects DOAC choice/dose
Self-check
- Which risks guide AF stroke prevention?
Thromboembolic + bleeding risk. - Can antiplatelet therapy substitute for AF anticoagulation?
No.
Drugs used for this (5)
All clinical uses · Open Atrial fibrillation (AF) — stroke prevention in the interactive console ↗